Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.36
Delayed Data
As of Apr 23
 -0.02 / -0.84%
Today’s Change
2.00
Today|||52-Week Range
7.15
-1.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues29.7M34.3M40.5M41.5M
 
 
 
 
 
Cost of Goods Sold10.0M10.5M10.5M13.5M
 
 
 
 
 
Depreciation And Amortization18.6M18.2M18.2M18.3M
 
 
 
 
 
 
Operating ExpensesGross Income1.2M5.6M11.7M9.8M
 
 
 
 
 
General Expenses20.8M19.1M20.3M17.4M
 
 
 
 
 
Research And Development528.0K82.0K99.0K78.0K
 
 
 
 
 
Total Operating Expenses49.4M47.8M49.1M49.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.6M-13.5M-8.7M-7.6M
 
 
 
 
 
Extraordinary Credit0.001.2M25.3M1.5M
 
 
 
 
Extraordinary Charge-800.0K-31.0K-884.0K-18.6M
 
 
 
 
 
Interest Expense On Debt9.0M9.2M9.3M9.5M
 
 
 
 
 
Other Expenses0.000.00-25.0K2.0M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.4M-21.6M6.4M-32.2M
 
 
 
 
 
Income Taxes-55.0K-40.0K-27.0K-251.0K
 
 
 
 
 
Net Income-29.5M-21.6M6.4M-32.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.0M10.0M11.1M11.7M
 
 
 
 
 
Shares To Calculate EPS Diluted10.0M10.0M16.5M11.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.94-$2.16$0.42-$2.78
 
 
 
 
 
EPS Diluted-$2.94-$2.16$0.42-$2.78